Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation - CD34 + , CD34 + 38 - , and week-6 CAFC assays predict poor engraftment

Author： Robinson S.N.   Freedman A.S.   Neuberg D.S.   Nadler L.M.   Mauch P.M.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.28, Iss.12, 2000-12, pp. : 1325-1333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transplantation with selected autologous peripheral blood CD34 + Thy1 + hematopoietic stem cells (HSCs) in multiple myeloma - Impact of HSC dose on engraftment, safety, and immune reconstitution

By Michallet M.   Philip T.   Philip I.   Godinot H.   Sebban C.   Salles G.   Thiebaut A.   Biron P.   Lopez F.   Mazars P.   Roubi N.   Leemhuis T.   Hanania E.   Reading C.   Fine G.   Atkinson K.   Juttner C.   Coiffier B.   Fiere D.   Archimbaud  

Experimental Hematology, Vol. 28, Iss. 7, 2000-07 ,pp. : 858-870

Elsevier

Access to resources Recommend Favorite

CD34 + cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation

By Lanza F.   Campioni D.   Moretti S.   Dominici M.   Punturieri M.   Focarile E.   Pauli S.   Dabusti M.   Tieghi A.   Bacilieri M.   Scapoli C.   De Angeli C.   Galluccio L.   Castoldi G.  

Experimental Hematology, Vol. 29, Iss. 12, 2001-12 ,pp. : 1484-1493

Elsevier

Access to resources Recommend Favorite

Kinetics of engraftment of CD34 - and CD34 + cells from mobilized blood differs from that of CD34 - and CD34 + cells from bone marrow

By Verfaillie C.M.   Almeida-Porada G.   Wissink S.   Zanjani E.D.  

Experimental Hematology, Vol. 28, Iss. 9, 2000-09 ,pp. : 1071-1079

Elsevier

Access to resources Recommend Favorite

Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation

By Hicks C.   Wong R.   Manoharan A.   Kwan Y.  

Annals of Hematology, Vol. 86, Iss. 8, 2007-08 ,pp. : 591-598

Springer Publishing Company

Access to resources Recommend Favorite

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

By Ilhan O.   Arslan O.   Arat M.   Beksac M.   Akan H.   Ozcan M.   Gurman G.   Konuk N.   Uysal A.   Koc H.  

Transfusion and Apheresis Science, Vol. 20, Iss. 1, 1999-02 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite